ArticleBiochemistry and biophysics reports2026
Viral dsRNA drives hyperinflammatory but blunted antiviral responses with enhanced PD-L1 induction in a COPD-like airway epithelial model.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Programmed death-ligand 1 (PD-L1) suppresses T-cell activation during antiviral immune responses, and its expression is increased in airway epithelial cells after viral infection. Because chronic obstructive pulmonary disease (COPD) is characterized by excessive airway inflammation and frequent virus-triggered exacerbations, we investigated the regulation and possible functional relevance of PD-L1 in a COPD-like airway epithelial model in response to viral double-stranded ribonucleic acid (dsRNA) stimulation. Human bronchial epithelial 16HBE14o-cells and β/γ epithelial sodium channel (ENaC)-overexpressing 16HBE14o- (β/γENaC-16HBE14o-) cells were stimulated with polyinosinic:polycytidylic acid [poly(I:C)]. In β/γENaC-16HBE14o-cells, poly(I:C) markedly enhanced the expression of pro-inflammatory mediators, including Toll-like receptor 3 (TLR3), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), along with increased p38 phosphorylation and nuclear accumulation of nuclear factor kappa B (NF-κB) subunits. In contrast, antiviral signaling was attenuated, as shown by reduced interferon regulatory factor 3 (IRF3) phosphorylation and weaker interferon-β (IFN-β) induction compared with parental cells. Notably, poly(I:C)-induced PD-L1 expression was significantly higher in β/γENaC-16HBE14o-cells than in normal airway epithelial cells. Pharmacological inhibition experiments showed that PD-L1 induction depended on p38 signaling rather than NF-κB. In a co-culture system, blockade of programmed cell death-1 (PD-1)/PD-L1 interaction with BMS202 tended to increase IL-2 production by Jurkat T cells exposed to poly(I:C)-stimulated β/γENaC-16HBE14o-cells, with a large effect size. These findings suggest that COPD-like airway epithelial cells display exaggerated inflammatory responses but impaired antiviral responses to viral dsRNA, accompanied by enhanced p38-dependent PD-L1 induction, which may contribute to reduced T-cell activation during COPD exacerbation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.